BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23286794)

  • 1. Poikilodermatous mycosis fungoides.
    Bloom B; Marchbein S; Fischer M; Kamino H; Patel R; Latkowski JA
    Dermatol Online J; 2012 Dec; 18(12):4. PubMed ID: 23286794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poikilodermatous mycosis fungoides with a CD8+ CD56+ immunophenotype: a case report and literature review.
    Shiomi T; Monobe Y; Kuwabara C; Hayashi H; Yamamoto T; Sadahira Y
    J Cutan Pathol; 2013 Mar; 40(3):317-20. PubMed ID: 23241021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and course of CD8+ cytotoxic variant of mycosis fungoides: a case series of seven patients.
    Nikolaou VA; Papadavid E; Katsambas A; Stratigos AJ; Marinos L; Anagnostou D; Antoniou C
    Br J Dermatol; 2009 Oct; 161(4):826-30. PubMed ID: 19558552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poikilodermatous mycosis fungoides.
    Farley-Loftus R; Mandal R; Latkowski JA
    Dermatol Online J; 2010 Nov; 16(11):8. PubMed ID: 21163159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poikilodermatous mycosis fungoides.
    Mataix J; Bañuls J; Lucas A; Belinchón I; Betlloch I
    Int J Dermatol; 2007 Sep; 46(9):950-1. PubMed ID: 17822499
    [No Abstract]   [Full Text] [Related]  

  • 6. A study of clinicopathologic profile of 15 cases of hypopigmented mycosis fungoides.
    Khopkar U; Doshi BR; Dongre AM; Gujral S
    Indian J Dermatol Venereol Leprol; 2011; 77(2):167-73. PubMed ID: 21393946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poikilodermatous Mycosis Fungoides: Comparative Study of Clinical, Histopathological and Immunohistochemical Features.
    Vasconcelos Berg R; Valente NYS; Fanelli C; Wu I; Pereira J; Zatz R; Sanches JA
    Dermatology; 2020; 236(2):117-122. PubMed ID: 31550709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poikilodermatous mycosis fungoides: clinical and histopathological analysis of a case and literature review.
    Pankratov O; Gradova S; Tarasevich S; Pankratov V
    Acta Dermatovenerol Alp Pannonica Adriat; 2015; 24(2):37-41. PubMed ID: 26086166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycosis fungoides associated with unusual epidermal hyperplasia.
    Puig L; Musulén E; Fernández-Figueras MT; Miralles J; Sitjas D; De Moragas JM
    Clin Exp Dermatol; 1996 Jan; 21(1):61-4. PubMed ID: 8689775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poikilodermatous and verrucous mycosis fungoides.
    Wakelin SH; Stewart EJ; Emmerson RW
    Clin Exp Dermatol; 1996 May; 21(3):205-8. PubMed ID: 8914361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poikilodermatous mycosis fungoides: a study of its clinicopathological, immunophenotypic, and prognostic features.
    Abbott RA; Sahni D; Robson A; Agar N; Whittaker S; Scarisbrick JJ
    J Am Acad Dermatol; 2011 Aug; 65(2):313-319. PubMed ID: 21529998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poikilodermatous mycosis fungoides and atrophic large-plaque parapsoriasis exhibit similar abnormalities of T-cell antigen expression.
    Lindae ML; Abel EA; Hoppe RT; Wood GS
    Arch Dermatol; 1988 Mar; 124(3):366-72. PubMed ID: 3257858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4/CD8 dual-positive mycosis fungoides: a previously unrecognized variant.
    Knapp CF; Mathew R; Messina JL; Lien MH
    Am J Dermatopathol; 2012 May; 34(3):e37-9. PubMed ID: 22356917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: a case series of 34 patients.
    Boulos S; Vaid R; Aladily TN; Ivan DS; Talpur R; Duvic M
    J Am Acad Dermatol; 2014 Dec; 71(6):1117-26. PubMed ID: 25264240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Papular mycosis fungoides].
    Brajon D; Bonnet N; Dales JP; Berbis P
    Ann Dermatol Venereol; 2013; 140(6-7):455-8. PubMed ID: 23773745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poikiloderma vasculare atrophicans showing features of ashy dermatosis in the beginning.
    Jeon J; Kim JH; Ahn JW; Song HJ
    Ann Dermatol; 2015 Apr; 27(2):197-200. PubMed ID: 25834361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
    Agar NS; Wedgeworth E; Crichton S; Mitchell TJ; Cox M; Ferreira S; Robson A; Calonje E; Stefanato CM; Wain EM; Wilkins B; Fields PA; Dean A; Webb K; Scarisbrick J; Morris S; Whittaker SJ
    J Clin Oncol; 2010 Nov; 28(31):4730-9. PubMed ID: 20855822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poikilodermatous Mycosis Fungoides - Rare Entity, Different Treatment Modalities.
    Jerković Gulin S; Čeović R; Ilić I; Bradamante M; Bukvić Mokos Z; Kostović K
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):48-52. PubMed ID: 29782300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitiligo vs. hypopigmented mycosis fungoides (histopathological and immunohistochemical study, univariate analysis).
    El-Darouti MA; Marzouk SA; Azzam O; Fawzi MM; Abdel-Halim MR; Zayed AA; Leheta TM
    Eur J Dermatol; 2006; 16(1):17-22. PubMed ID: 16436337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycosis fungoides.
    Brecher A
    Dermatol Online J; 2003 Oct; 9(4):23. PubMed ID: 14594596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.